Augmedix Buy Hold or Sell Recommendation

AUGXDelisted Stock  USD 2.35  0.00  0.00%   
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Augmedix is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Augmedix given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Augmedix, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
In addition, we conduct extensive research on individual companies such as Augmedix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Augmedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Execute Augmedix Buy or Sell Advice

The Augmedix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Augmedix. Macroaxis does not own or have any residual interests in Augmedix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Augmedix's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell AugmedixBuy Augmedix
Not Rated
For the selected time horizon Augmedix has a Risk Adjusted Performance of 0.1057, Jensen Alpha of 2.3, Total Risk Alpha of (0.75), Sortino Ratio of 0.8527 and Treynor Ratio of (5.77)
We provide trade advice to complement the prevailing expert consensus on Augmedix. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Augmedix is not overpriced, please confirm all Augmedix fundamentals, including its net income, and the relationship between the number of shares shorted and book value per share . Please also double-check Augmedix number of shares shorted to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Augmedix Trading Alerts and Improvement Suggestions

Augmedix is not yet fully synchronised with the market data
Augmedix has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 44.85 M. Net Loss for the year was (19.17 M) with profit before overhead, payroll, taxes, and interest of 13.95 M.
Augmedix currently holds about 29.99 M in cash with (15.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Over 85.0% of the company shares are held by institutions such as insurance companies

Augmedix Returns Distribution Density

The distribution of Augmedix's historical returns is an attempt to chart the uncertainty of Augmedix's future price movements. The chart of the probability distribution of Augmedix daily returns describes the distribution of returns around its average expected value. We use Augmedix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Augmedix returns is essential to provide solid investment advice for Augmedix.
Mean Return
2.26
Value At Risk
-1.09
Potential Upside
2.25
Standard Deviation
17.99
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Augmedix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 31994 shares by Ian Shakil of Augmedix at 0.64 subject to Rule 16b-3 [view details]

Augmedix Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Augmedix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Augmedix Buy or Sell Advice

When is the right time to buy or sell Augmedix? Buying financial instruments such as Augmedix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Augmedix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Retail Thematic Idea Now

Retail
Retail Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Augmedix Stock

If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world